Ultraformer MPT vs Doublo Gold: How Korean Ultrasound Lifting Device Generations Differ (Complete Guide)
Device consoles look alike across platforms. What changes the result is the cartridge depth, the pulse pattern and the hand holding the transducer. Photo: Judy Beth Morris / Unsplash
Quick answer Ultraformer MPT and Doublo Gold are both Korean-made high-intensity focused ultrasound lifting platforms, but they belong to different device families: Ultraformer MPT (Classys) uses micro-pulsed energy delivery, while the Doublo line (Hironic) uses conventional focused-ultrasound shots. No published head-to-head trial compares these two devices directly. Choosing between them is therefore a question of cartridge range, session planning and operator experience, not a proven efficacy gap. For the modality as a whole, a 2025 meta-analysis of 42 studies reported investigator-rated improvement of 89% and patient-rated improvement of 84%, with mild and transient side effects [2].
In this guide
Ultrasound lifting is one of the most requested non-surgical treatments among international patients arriving in Seoul, and two platform names come up constantly in clinic price lists: Ultraformer MPT and Doublo Gold. Both are Korean-manufactured, both are marketed for lifting and tightening, and both are frequently presented as interchangeable. They are not quite interchangeable, but the real differences are narrower, and more practical, than most marketing copy suggests. This guide separates what is documented from what is claimed, and gives you the questions that actually change your outcome.
What Ultraformer MPT and Doublo Gold actually are
Both devices deliver high-intensity focused ultrasound (HIFU). Energy is focused at a set depth beneath the skin surface, where it produces small zones of thermal coagulation. Those zones trigger a wound-healing and collagen-remodelling response over the following weeks to months. The surface is largely spared, which is why there is no open wound and little or no downtime.
Ultraformer MPT is made by Classys, a Korean aesthetic-device manufacturer. It is the successor generation to the widely distributed Ultraformer III. The “MPT” designation refers to the micro-pulsed delivery mode that distinguishes it from the earlier platform.
Doublo Gold comes from Hironic, another Korean manufacturer, and sits within the long-running Doublo family. The Doublo name has been in Korean clinics for well over a decade across successive revisions, which is part of why it appears so often on older price lists.
Neither is in the same category as a visualisation-equipped device. Platforms such as Ulthera pair focused ultrasound with real-time imaging so the operator can see the tissue planes before firing, and the published evidence base labelled “MFU-V” refers specifically to that imaging-equipped approach [2]. Ultraformer MPT and Doublo Gold are non-visualisation platforms, which places more weight on the operator's anatomical judgement. For the imaging comparison, see our Shurink Universe vs Ulthera breakdown.
Micro-pulsed versus conventional delivery
The headline technical difference is how long the transducer dwells at each focal point. Conventional focused-ultrasound platforms fire a shot and hold energy at the focal point for a relatively longer interval. Micro-pulsed delivery, as implemented on Ultraformer MPT, breaks the same delivery into shorter bursts.
Manufacturers describe two intended consequences. The first is comfort: shorter bursts are promoted as reducing the sharp, deep ache many patients report during focused-ultrasound treatment. The second is coverage pattern, meaning a different distribution of coagulation points across the same treated area.
Treat both as plausible engineering claims rather than settled clinical fact. We could not identify peer-reviewed, independent head-to-head data showing that micro-pulsed delivery produces superior lifting over conventional delivery in matched patients. What the literature does establish is that pain during focused-ultrasound treatment is real and measurable: the 2025 meta-analysis pooled a mean pain score of 4.85 out of 10 across 785 patients [2]. A platform that genuinely reduces that number is offering something patients value, even if it does not change the final lift.
Practically, this means a “newer generation, better result” claim is not by itself a reason to pay a premium. Ask instead how many shots your plan includes and at which depths. Those two numbers track outcome more closely than the platform's generation label.
Cartridge depths and the layers they target
Both families work through interchangeable cartridges, each fixed to a focal depth. The cartridge selection, not the console, determines which tissue layer receives energy. Clinics in Korea commonly stock the facial depths below, and body cartridges go deeper still. Confirm the exact set your clinic holds, since availability varies by platform revision and by clinic.
Typical focal depth | Tissue layer targeted | Usual treatment intent |
1.5 mm | Superficial dermis | Fine lines, skin texture, periocular and forehead detail |
3.0 mm | Deep dermis and subdermal plane | Mid-face firmness, overall tightening |
4.5 mm | Deeper fibromuscular plane | Jawline and lower-face lifting vectors |
6.0 mm and deeper | Subcutaneous fat (body cartridges) | Body contouring and submental fullness |
A plan that uses only one depth is doing one job. Most Korean clinics stack two or three depths in a single session so that superficial texture and deeper structural support are addressed together. If your quotation lists a shot count but no depths, it is an incomplete quotation. The same logic applies across the HIFU category, and our cartridge-depth and session-planning guide sets out how depth stacking is usually sequenced.
What the published evidence covers, and what it does not
This is where careful reading matters most. The peer-reviewed literature on focused ultrasound for facial lifting is reasonably substantial, but almost none of it is device-comparative, and the strongest syntheses concern imaging-equipped platforms rather than the two devices in this article's title.
A 2023 systematic review screened 693 records and included 16 studies. It reported brow elevation of 0.47 to 1.7 mm and submental area reductions of 26 to 45 mm2 on lateral photographs, with 92% of patients showing improvement on a pooled investigator scale at day 90 [1]. Patient-reported improvement was more modest, rising from 42% at 90 days to 53% at 360 days [1], a gap worth noticing because it means clinicians consistently see more change than patients feel.
The 2025 meta-analysis of 42 studies put investigator-rated global improvement at 89% (95% CI 81 to 94%) and patient-rated improvement at 84% (95% CI 73 to 91%) [2]. Satisfaction split sharply by region: 93% for face and neck versus 63% for other body areas [2].
What is missing is equally important. The 2025 authors noted that many included studies lacked control groups, randomisation or blinding, that reporting of patient ethnicity was insufficient, and that publication bias was detected for investigator-rated improvement and satisfaction [2]. So the direction of effect is well supported, while the precise magnitude, and how it transfers to any single device, is not.
Ask for the platform name and the cartridge depths to be written on your consent form before the first shot. Photo: Trnava University / Unsplash
Pain, session length and recovery
Expect a deep, intermittent ache rather than surface pain, concentrated at the deeper cartridge depths and over bony areas such as the jawline and brow. Pooled data place the average near the middle of a 0 to 10 scale [2], which matches what most patients describe: uncomfortable but tolerable, and over when the session ends.
Topical anaesthetic cream is standard in Korean clinics. Some clinics add oral analgesia or nerve-block injections for higher-density plans. Because pain-management protocols varied so widely across studies, the 2025 review could not analyse their effect separately [2], which means your clinic's protocol is a fair thing to discuss rather than a fixed medical standard.
A full-face session typically runs 30 to 60 minutes depending on shot count. Transient erythema with or without oedema is the expected immediate finding. The 2023 review classified other adverse effects as rare at around 2%, including dysesthesia, bruising and, in isolated cases, mandibular burns [1]. The 2025 synthesis similarly found erythema, oedema and swelling to be most common, all mild to moderate, with no serious adverse events reported in the included studies [2].
For international patients, the practical consequence is scheduling-friendly: there is no wound to protect, so flights are generally not restricted by the treatment itself. Confirm this against your own plan, particularly if focused ultrasound is combined with injectables or surgery on the same trip.
How Korean clinics price and package these treatments
Ultrasound lifting in Korea is almost always priced per shot count, per cartridge depth, or as a bundled package of both. Two quotations naming the same device can differ severalfold because one includes 300 shots at a single depth and the other 600 shots across three depths. Comparing platform names alone tells you almost nothing about value.
Three line items are worth isolating before you commit. First, the shot count per depth, written out separately. Second, whether a touch-up or second session is included and within what window. Third, whether consultation, topical anaesthetic and any post-treatment care are inside the quoted figure or billed on the day.
Scale explains some of the pricing pressure. The American Society of Plastic Surgeons recorded 439,032 non-surgical skin-tightening procedures in the United States in 2024, within 28,243,407 minimally invasive cosmetic procedures overall [4], a mature high-volume category where competition runs on price and packaging. Korea's inbound medical-travel market adds its own dynamics, tracked in the annual statistical reports published by the Korea Health Industry Development Institute [5].
If you are weighing ultrasound against radiofrequency on price, the mechanisms differ enough that cost should not be the deciding factor. Our HIFU versus Thermage comparison and the monopolar RF platform breakdown set out where each one fits.
Who each platform suits, and when surgery is the better question
Focused ultrasound rewards mild to moderate laxity in patients who want no downtime and accept a gradual, partial change. It does not substitute for excisional surgery, and the literature is explicit that results degrade as laxity increases. The 2023 review identified excessive skin laxity and a body mass index above 30 as relative contraindications precisely because outcomes declined in those groups [1].
Between the two platforms, the honest guidance is unglamorous. If your priority is comfort during the session, the micro-pulsed argument for Ultraformer MPT is reasonable and worth asking about. If your clinic has run a Doublo platform for years with consistent protocols, that accumulated operator familiarity is a genuine asset. Device vintage is a weaker predictor of your result than the depth plan and the person performing it.
Before you book: three realistic expectations Change is gradual. Collagen remodelling means the visible endpoint usually arrives 2 to 3 months after the session, not the week after. Clinicians see more than patients feel. Investigator-rated improvement ran well ahead of patient-rated improvement in pooled data [1]. Judge against standardised photographs, not memory. Significant sagging needs a surgical conversation. If a clinic promises a surgical-grade lift from focused ultrasound alone, that is a reason to get a second opinion, not to book. |
This article is general information, not a treatment recommendation. Suitability can only be established in person by a licensed physician who has examined your skin and discussed your history.
What to ask a Korean clinic before you book
The questions below separate clinics that plan from clinics that sell. Send them by message before you travel, since the specificity of the reply is itself information.
Which exact platform and model will be used, and will it be named on my consent form?
How many shots at each cartridge depth are included, listed depth by depth?
Who operates the handpiece, a physician or a nurse under supervision, and what is their experience with this platform?
What pain management is included, and what are the options if the session proves intolerable?
Is a touch-up session included, and if so within what time window?
Will standardised before-and-after photographs be taken under consistent lighting and angle?
What is the written policy if I see no change at three months?
Verifying the clinic matters at least as much as verifying the device. Our 15-point clinic verification checklist covers specialist credentials, facility registration and the documentation you should receive before paying a deposit.
What the research says
Systematic review of microfocused ultrasound for facial tightening (2023)
Contini and colleagues screened 693 records and included 16 studies: randomised trials, controlled trials, cohort studies and case series of at least ten patients. All included studies enrolled female patients. Pooled analysis covered 337 patients for day-90 investigator scores and 81 for day-90 patient scores. Measured outcomes included brow elevation of 0.47 to 1.7 mm and submental area reduction of 26 to 45 mm2 on lateral photographs, with 92% of patients improved on the investigator scale at day 90. Patient-perceived improvement was mild, 42% at 90 days rising to 53% at 360 days. Treatment was described as moderately painful with transient erythema and oedema, and other adverse effects were rare at around 2%. Limitation: no longer-term follow-up data were available, and all participants were female. What this means for you: expect a measurable but millimetre-scale change that a clinician will see more readily than you will, and ask for standardised photography so you can judge it fairly [1].
Systematic review and meta-analysis of MFU-V (2025)
Amiri and colleagues identified 4,019 references and included 42 studies, with individual sample sizes from 10 to 459. Meta-analysed subsets covered 411 patients for investigator-rated improvement, 312 for patient-rated improvement, 326 for satisfaction and 785 for pain. Investigator-rated global improvement was 89% (95% CI 81 to 94%) and patient-rated 84% (95% CI 73 to 91%). Satisfaction averaged 84% but split by region: 93% for face and neck against 63% elsewhere. Mean pain was 4.85 of 10. Erythema, oedema and swelling were the commonest adverse events, all mild to moderate, with no serious events in the included studies. Limitations: many studies lacked controls, randomisation or blinding, ethnicity reporting was insufficient, and publication bias was detected for investigator improvement and satisfaction. What this means for you: the face and neck are where this modality has the strongest support, and body-area satisfaction is materially lower, which is a reason to question body packages harder than facial ones [2].
Korean single-centre study across seven facial areas (2015)
Park and colleagues treated 20 Korean patients, 18 women and 2 men, aged 37 to 75 with a mean of 52.3 years and Fitzpatrick skin types III and IV, using a single focused-ultrasound session averaging 420 plus or minus 59.1 shots, assessed at 3 and 6 months by two blinded clinicians using standardised photographs. Improvement was seen across all seven treated areas, with jawline, cheek and perioral areas ranked most responsive. At 12 months, 4 of the 15 patients who replied still reported partial effect in some areas. Adverse events were erythema and swelling in 6 patients and purpura or bruising in 2, resolving within two weeks. Limitations: small sample, no control group, and the study is now over a decade old, so device generations have changed since. What this means for you: this remains one of the few data points on Fitzpatrick III to IV Asian skin specifically, and it supports the common Korean clinical practice of prioritising the jawline and lower face [3].
Frequently asked questions
Is Ultraformer MPT better than Doublo Gold?
No published head-to-head trial supports ranking one above the other. Ultraformer MPT's micro-pulsed delivery is promoted for comfort, and the Doublo line has a long Korean clinical track record. In practice the depth plan, shot count and operator experience influence your result more than which of the two consoles is in the room.
How long before I see a result?
The mechanism is collagen remodelling, so change accumulates. Most clinics assess at 2 to 3 months. Pooled data show investigator-rated improvement persisting through day 90 and beyond [1], with patient-perceived improvement continuing to rise between 90 and 360 days [1].
How painful is it, realistically?
A pooled mean of 4.85 on a 0 to 10 scale across 785 patients [2]. Most people describe a deep intermittent ache at the deeper cartridge depths, worst over the jawline and brow. Topical anaesthetic is standard in Korean clinics, and it is worth asking what else is available before the session begins.
Can focused ultrasound replace a facelift?
No. It is intended for mild to moderate laxity. The 2023 systematic review identified excessive skin laxity and a BMI above 30 as relative contraindications because results declined in those groups [1]. If a clinic promises surgical-grade lifting from ultrasound alone, seek a second opinion.
Can I fly home the same week?
There is no open wound and downtime is typically limited to transient redness and swelling, so flights are not generally restricted by the treatment itself. Confirm against your own plan, especially if the session is combined with injectables or surgery during the same trip.
References
Contini M, Hollander MHJ, Vissink A, et al. A Systematic Review of the Efficacy of Microfocused Ultrasound for Facial Skin Tightening. International Journal of Environmental Research and Public Health, 2023. PMID 36674277. DOI 10.3390/ijerph20021522
Amiri M, Ajasllari G, Llane A, et al. Microfocused Ultrasound With Visualization (MFU-V) Effectiveness and Safety: A Systematic Review and Meta-Analysis. Aesthetic Surgery Journal, 45(3):86-94, 2025. PMID 39540440. DOI 10.1093/asj/sjae228
Park H, Kim E, Kim J, Ro Y, Ko J. High-Intensity Focused Ultrasound for the Treatment of Wrinkles and Skin Laxity in Seven Different Facial Areas. Annals of Dermatology, 27(6):688-693, 2015. DOI 10.5021/ad.2015.27.6.688
American Society of Plastic Surgeons. 2024 Minimally Invasive Procedure Trends. ASPS Procedural Statistics, 2025.
Korea Health Industry Development Institute (KHIDI). Overseas Patient Attraction: Statistical Reports. KHIDI Bio-Health Industry Information, accessed 2026-10-25.
Related reading
About this guide. Korean Plastic Surgery Info is an independent information resource for international patients considering treatment in South Korea. We do not own, operate or hold any interest in a clinic or hospital, and we receive no referral fee or commission for any clinic mentioned. Device and protocol details vary by clinic and by platform revision and should be confirmed directly with the provider. This article summarises published literature and official statistics for general educational purposes. It is not medical advice, not a diagnosis and not a treatment recommendation, and it cannot substitute for in-person assessment by a licensed physician. Last reviewed 25 October 2026.
Comments